V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290008156 | 290004649 | 1.78 | 101.3 | Palliative (P) | 2014-10-30 | 2015-01-22 | CARBOPLATIN + RT | N | N | 290017616 | CAPECITABINE + OXALIPLATIN |
| 290008157 | 290004653 | 1.77 | 96.1 | Palliative (P) | 2017-10-09 | 2018-03-20 | Trial Unspecified | N | N | 290017656 | CAPECITABINE + CISPLATIN + STREPTOZOCIN |
| 290008158 | 290004657 | 1.73 | 55.5 | Palliative (P) | 2017-04-07 | 2017-04-07 | CETUXIMAB | 1 | N | 290017662 | CISPLATIN + RALTITREXED + TRASTUZUMAB |
| 290008159 | 290006982 | 1.73 | 71.7 | Palliative (P) | 2015-06-20 | 2015-06-29 | Oxaliplatin + Raltitrexed | N | N | 290017970 | CAPECITABINE |
| 290008160 | 290004685 | 1.71 | 48.5 | Palliative (P) | 2016-05-08 | 2016-05-08 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 290017974 | TRIAL |
| 290008161 | 290004697 | 1.73 | 103.2 | Adjuvant (A) | 2016-06-18 | 2016-07-08 | CAPECITABINE + OXALIPLATIN | 2 | N | 290018051 | CISPLATIN + RT |
| 290008162 | 290004704 | 1.52 | 0 | Palliative (P) | 2016-03-27 | 2016-04-11 | NIVOLUMAB | N | N | 290018167 | CAPECITABINE + STREPTOZOCIN |
| 290008163 | 290004711 | 1.7 | 61.9 | Palliative (P) | 2017-07-03 | 2017-07-10 | LANREOTIDE | Y | N | 290018198 | CETUXIMAB + CISPLATIN + FU |
| 290008164 | 290004714 | 1.77 | null | Palliative (P) | 2018-10-10 | 2018-12-06 | LANREOTIDE | 01 | null | 290018209 | OCTREOTIDE |
| 290008165 | 290004720 | null | 65.1 | null | 2018-12-29 | 2018-12-29 | CARBOPLATIN | N | N | 290018245 | CETUXIMAB |
| 290008166 | 290004723 | 1.7 | 92 | Palliative (P) | 2015-08-02 | 2015-08-02 | PEMBROLIZUMAB | 2 | N | 290018248 | TRASTUZUMAB + VINORELBINE |
| 290008167 | 290004726 | 0 | 96 | Palliative (P) | 2011-11-21 | 2017-09-04 | FLUOROURACIL + Panitumumab | N | null | 290018249 | EOX |
| 290008168 | 290004732 | 1.54 | 50.8 | Palliative (P) | 2017-06-11 | 2017-06-15 | PACLITAXEL | 02 | null | 290018280 | CARBOPLATIN + CETUXIMAB + FU |
| 290008170 | 290007926 | 1.6 | 77.2 | Palliative (P) | 2017-10-28 | 2018-07-05 | Capecitabine | N | N | 290018451 | TRABECTEDIN |
| 290008171 | 290004764 | 1.59 | 67.25 | Disease modification (D) | 2017-07-12 | 2017-08-30 | INTERAACT trial | 02 | N | 290018470 | CHOP R |
| 290008172 | 290004765 | 0 | 67.5 | Palliative (P) | 2013-11-14 | 2013-11-16 | CETUXIMAB + CISPLATIN + FU | N | N | 290018476 | CAPECITABINE |
| 290008173 | 290007024 | 2 | 111 | Palliative (P) | null | 2018-06-17 | Cisplatin + Radiotherapy | N | N | 290018548 | AFLIBERCEPT + FU + IRINOTECAN |
| 290008174 | 290007029 | null | 95.7 | Palliative (P) | 2017-11-16 | 2017-11-17 | Cetuximab 7 day (Cycle 1) | 2 | N | 290018616 | NOT MATCHED |
| 290008175 | 290004793 | 1.6 | 0 | Palliative (P) | 2019-02-15 | 2019-02-27 | Capecitabine (14 day) + Irinotecan | N | N | 290018681 | CAPECITABINE |
| 290008176 | 290004797 | 1.61 | 95 | Palliative (P) | 2016-02-22 | 2016-04-09 | PEMBROLIZUMAB | N | Y | 290018686 | SUNITINIB |
| 290008177 | 290007036 | 1.55 | 95 | null | 2017-05-07 | 2017-05-22 | PACLITAXEL | N | N | 290018689 | CAPECITABINE |
| 290008178 | 290004804 | 1.7 | 68 | Curative (C) | 2018-01-28 | 2018-01-28 | LANREOTIDE | 02 | N | 290018743 | CARBOPLATIN + RT |
| 290008179 | 290004815 | 1.63 | 33.5 | Curative (C) | 2016-09-21 | 2016-10-10 | Capecitabine | 02 | N | 290018789 | CARBOPLATIN + RT |
| 290008180 | 290004834 | 1.52 | null | null | 2017-11-23 | 2017-11-23 | Capecitabine | N | N | 290018953 | LANREOTIDE |
| 290008181 | 290004842 | 1.78 | 74.9 | Palliative (P) | 2018-04-23 | 2018-04-24 | Capecitabine | N | N | 290019011 | EOX |
| 290008182 | 290004847 | 1.6 | 64.5 | Disease modification (D) | 2016-08-09 | 2016-08-09 | Cisplatin + Radiotherapy | 02 | N | 290019042 | BCG |
| 290008183 | 290004851 | 1.7 | null | Palliative (P) | 2018-02-09 | 2018-02-23 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | N | N | 290019080 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008184 | 290004853 | 1.78 | 83 | Palliative (P) | 2015-08-10 | 2015-08-10 | LANREOTIDE | 02 | N | 290019084 | CARBOPLATIN + PACLITAXEL |
| 290008185 | 290004868 | 1.8 | 53.7 | Curative (C) | 2016-10-08 | 2016-10-09 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | null | 290019175 | CARBO + FLUOROURACIL |
| 290008186 | 290004870 | 1.6 | 60 | Palliative (P) | 2014-11-26 | 2014-11-26 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 290019178 | PEMBROLIZUMAB |
| 290008187 | 290004872 | 1.65 | 83 | Palliative (P) | 2018-04-25 | 2018-07-05 | FLUOROURACIL + MITOMYCIN | N | null | 290019189 | PEMBROLIZUMAB |
| 290008188 | 290004877 | 1.64 | 76.3 | Curative (C) | 2017-12-18 | 2017-12-31 | Brentuximab Vedotin | 2 | Y | 290019233 | FLUOROURACIL + MITOMYCIN |
| 290008189 | 290007064 | 1.81 | null | Curative (C) | 2017-03-20 | 2017-03-26 | LANREOTIDE | null | N | 290019237 | CAPECITABINE + MITOMYCIN + RT |
| 290008190 | 290004890 | 1.57 | 44.35 | Palliative (P) | 2014-09-20 | 2014-09-23 | CHOP R - 21 days | N | N | 290019304 | SUNITINIB |
| 290008191 | 290004899 | null | 77.7 | Palliative (P) | 2018-09-11 | 2018-10-28 | TRASTUZUMAB | N | null | 290019407 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008192 | 290004908 | 1.8 | 75.5 | Palliative (P) | 2016-08-02 | 2016-08-10 | Trial Unspecified | N | N | 290019434 | CARBOPLATIN |
| 290008193 | 290004916 | 1.6 | 51.2 | null | 2016-09-09 | 2016-12-14 | CAPECITABINE + MITOMYCIN + RT | N | Y | 290019481 | CETUXIMAB + RT |
| 290008194 | 290007085 | 1.67 | null | Palliative (P) | 2018-02-14 | 2018-02-23 | Capecitabine + Streptozocin | 2 | N | 290019591 | OCTREOTIDE |
| 290008195 | 290004929 | 1.75 | 62.9 | null | 2018-10-18 | 2018-11-16 | Trial Unspecified | N | N | 290019597 | CISPLATIN |
| 290008196 | 290004935 | 1.8 | 119.9 | Palliative (P) | 2015-02-26 | 2015-08-07 | Cisplatin + Radiotherapy | 02 | N | 290019622 | PACLITAXEL |
| 290008197 | 290007953 | 1.46 | 61.1 | Disease modification (D) | 2015-04-19 | 2015-05-03 | Capecitabine | 2 | N | 290019647 | Y-90 |
| 290008198 | 290004943 | 0 | 90.4 | null | 2015-06-30 | 2015-07-17 | LANREOTIDE | 2 | N | 290019674 | LANREOTIDE |
| 290008199 | 290004961 | 1.79 | 65 | Not known (9) | 2015-09-06 | 2015-09-06 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 290019795 | DOCETAXEL |
| 290008200 | 290004967 | 1.64 | null | Adjuvant (A) | 2018-06-24 | 2018-07-20 | Capecitabine | null | N | 290019811 | CAPECITABINE + OXALIPLATIN |
| 290008201 | 290004981 | 1.77 | 51.6 | Curative (C) | 2018-09-05 | 2018-09-08 | Capecitabine | null | N | 290019956 | CARBOPLATIN + RT |
| 290008202 | 290005009 | 1.55 | 58.1 | Disease modification (D) | null | 2017-10-31 | LANREOTIDE | N | N | 290020156 | BORTEZOMIB |
| 290008203 | 290005010 | null | 67.8 | Palliative (P) | 2015-09-25 | 2015-09-27 | Everolimus 10mg | N | Y | 290020157 | REGORAFENIB |
| 290008204 | 290005016 | 1.82 | 99.6 | Palliative (P) | 2019-01-21 | 2019-03-08 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 290020188 | CAPECITABINE + CISPLATIN + RT |
| 290008205 | 290005041 | 1.87 | null | Curative (C) | null | 2019-06-08 | CARBOPLATIN + ETOPOSIDE | N | N | 290020347 | CISPLATIN + RT |
| 290008206 | 290005044 | 1.52 | 50.3 | Curative (C) | null | 2017-10-18 | CARBOPLATIN | N | N | 290020351 | CETUXIMAB + RT |